⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for stage iii bladder cancer

Every month we try and update this database with for stage iii bladder cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic CancerNCT00005842
Cancer
trastuzumab
tipifarnib
18 Years - National Cancer Institute (NCI)
Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung CancersNCT01846520
Healthy Subject
Localized Trans...
Metastatic Tran...
Psychosocial Ef...
Recurrent Bladd...
Recurrent Cervi...
Recurrent Colon...
Recurrent Gastr...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Pancr...
Recurrent Recta...
Recurrent Renal...
Recurrent Trans...
Recurrent Ureth...
Recurrent Uteri...
Regional Transi...
Stage II Bladde...
Stage II Renal ...
Stage II Urethr...
Stage IIA Cervi...
Stage IIA Colon...
Stage IIA Gastr...
Stage IIA Ovari...
Stage IIA Ovari...
Stage IIA Pancr...
Stage IIA Recta...
Stage IIA Uteri...
Stage IIB Cervi...
Stage IIB Colon...
Stage IIB Gastr...
Stage IIB Ovari...
Stage IIB Ovari...
Stage IIB Pancr...
Stage IIB Recta...
Stage IIB Uteri...
Stage IIC Colon...
Stage IIC Ovari...
Stage IIC Ovari...
Stage IIC Recta...
Stage III Bladd...
Stage III Pancr...
Stage III Renal...
Stage III Ureth...
Stage IIIA Cerv...
Stage IIIA Colo...
Stage IIIA Gast...
Stage IIIA Ovar...
Stage IIIA Ovar...
Stage IIIA Rect...
Stage IIIA Uter...
Stage IIIB Cerv...
Stage IIIB Colo...
Stage IIIB Gast...
Stage IIIB Ovar...
Stage IIIB Ovar...
Stage IIIB Rect...
Stage IIIB Uter...
Stage IIIC Colo...
Stage IIIC Gast...
Stage IIIC Ovar...
Stage IIIC Ovar...
Stage IIIC Rect...
Stage IIIC Uter...
Stage IV Bladde...
Stage IV Gastri...
Stage IV Ovaria...
Stage IV Ovaria...
Stage IV Pancre...
Stage IV Renal ...
Stage IV Urethr...
Stage IVA Cervi...
Stage IVA Colon...
Stage IVA Recta...
Stage IVA Uteri...
Stage IVB Cervi...
Stage IVB Colon...
Stage IVB Recta...
Stage IVB Uteri...
Ureter Cancer
Stage IIA Lung ...
Stage IIB Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
educational int...
telephone-based...
quality-of-life...
questionnaire a...
18 Years - City of Hope Medical Center
Combination Chemotherapy in Treating Patients With Advanced Bladder or Kidney CancerNCT00003342
Bladder Cancer
Transitional Ce...
filgrastim
carboplatin
doxorubicin hyd...
gemcitabine hyd...
paclitaxel
18 Years - Memorial Sloan Kettering Cancer Center
Radiation Therapy With or Without Chemotherapy in Treating Patients With Stage II or Stage III Bladder CancerNCT00024349
Bladder Cancer
fluorouracil
mitomycin C
radiation thera...
18 Years - National Cancer Institute (NCI)
Short-Term Low-Dose Interferon Alfa in Treating Patients With Cancer of the UrotheliumNCT00082719
Bladder Cancer
Urethral Cancer
Recombinant Int...
- M.D. Anderson Cancer Center
3-Dimensional Conformal Radiation Therapy in Treating Patients With Bladder Cancer Who Have Undergone Transurethral Resection of the BladderNCT01124682
Bladder Cancer
diagnostic cyst...
diffusion-weigh...
implanted fiduc...
quality-of-life...
3-dimensional c...
image-guided ra...
selective exter...
18 Years - National Cancer Institute (NCI)
S0219, Combination Chemotherapy Followed By Observation or Surgery in Patients With Stage II or Stage III Cancer of the UrotheliumNCT00045630
Bladder Cancer
Transitional Ce...
Urethral Cancer
carboplatin
gemcitabine
paclitaxel
surgery
18 Years - SWOG Cancer Research Network
Sunitinib as Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Transitional Cell CancerNCT00792025
Bladder Cancer
Transitional Ce...
sunitinib malat...
18 Years - National Cancer Institute (NCI)
Gemcitabine With Or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Bladder CancerNCT00627432
Bladder Cancer
gemcitabine hyd...
oxaliplatin
18 Years - National Cancer Institute (NCI)
Combination Chemotherapy in Treating Patients With Bladder CancerNCT00003701
Bladder Cancer
Urethral Cancer
carboplatin
cisplatin
doxorubicin hyd...
methotrexate
paclitaxel
vinblastine sul...
0 Years - 120 YearsEastern Cooperative Oncology Group
Radiation Therapy and Chemotherapy Following Surgery in Treating Patients With Stage II or Stage III Bladder CancerNCT00003642
Bladder Cancer
cisplatin
fluorouracil
radiation thera...
- 75 YearsEuropean Organisation for Research and Treatment of Cancer - EORTC
Radiation Therapy With or Without Chemotherapy in Treating Patients With Stage II or Stage III Bladder CancerNCT00024349
Bladder Cancer
fluorouracil
mitomycin C
radiation thera...
18 Years - National Cancer Institute (NCI)
Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder CancerNCT00003930
Bladder Cancer
cisplatin
gemcitabine hyd...
paclitaxel
conventional su...
radiation thera...
18 Years - Radiation Therapy Oncology Group
Radiation Therapy With or Without Carbogen and Niacinamide in Treating Patients With Bladder CancerNCT00033436
Bladder Cancer
niacinamide
carbogen
radiation thera...
18 Years - National Cancer Institute (NCI)
Sunitinib Malate in Treating Patients With Locally Recurrent, Locally Advanced, Unresectable, or Metastatic Urinary Tract CancerNCT01118039
Bladder Cancer
Transitional Ce...
Urethral Cancer
sunitinib malat...
immunohistochem...
laboratory biom...
pharmacological...
quality-of-life...
18 Years - National Cancer Institute (NCI)
Loop Resectoscope in Treating Patients With Bladder Cancer or Benign Prostatic Hyperplasia Who Are Undergoing Transurethral ResectionNCT00303654
Bladder Cancer
biopsy
therapeutic con...
- National Cancer Institute (NCI)
Radiation Therapy and Chemotherapy Following Surgery in Treating Patients With Stage II or Stage III Bladder CancerNCT00003642
Bladder Cancer
cisplatin
fluorouracil
radiation thera...
- 75 YearsEuropean Organisation for Research and Treatment of Cancer - EORTC
Carboplatin and Gemcitabine Hydrochloride With or Without Vandetanib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urinary Tract CancerNCT01191892
Bladder Cancer
Transitional Ce...
Ureter Cancer
Urethral Cancer
carboplatin
gemcitabine hyd...
vandetanib
Placebo
18 Years - 120 YearsCardiff University
Gemcitabine, Paclitaxel, Doxorubicin in Metastatic or Unresectable Bladder Cancer With Decreased Kidney FunctionNCT00478361
Distal Urethral...
Metastatic Tran...
Proximal Urethr...
Recurrent Bladd...
Recurrent Trans...
Recurrent Ureth...
Regional Transi...
Stage III Bladd...
Stage IV Bladde...
Transitional Ce...
Urethral Cancer...
Gemcitabine hyd...
Paclitaxel
Doxorubicin hyd...
Pegfilgrastim
- M.D. Anderson Cancer Center
Docetaxel and St. John's Wort in Treating Patients With Solid Tumors That Cannot Be Removed By SurgeryNCT00041171
Adult Solid Tum...
Breast Cancer
Head and Neck C...
Kidney and Urin...
Male Reproducti...
Thorax and Resp...
Hypericum perfo...
docetaxel
placebo
18 Years - 120 YearsAlliance for Clinical Trials in Oncology
Transurethral Resection and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder CancerNCT00003640
Bladder Cancer
filgrastim
cisplatin
doxorubicin hyd...
methotrexate
vinblastine sul...
surgical proced...
radiation thera...
- European Organisation for Research and Treatment of Cancer - EORTC
Docetaxel in Treating Patients With Solid TumorsNCT00003565
Bladder Cancer
Breast Cancer
Head and Neck C...
Lung Cancer
Unspecified Adu...
docetaxel
18 Years - Alliance for Clinical Trials in Oncology
Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer That Was Removed by SurgeryNCT00777491
Bladder Cancer
induction cispl...
induction 5-flu...
induction gemci...
Induction BID r...
Induction QD ra...
Consolidation B...
Consolidation Q...
consolidation g...
consolidation 5...
consolidation c...
radical cystect...
Post-Induction ...
adjuvant gemcit...
adjuvant cispla...
18 Years - 120 YearsRadiation Therapy Oncology Group
Cisplatin, Bevacizumab, and Gemcitabine Followed by Surgery, Bevacizumab, and Paclitaxel in Treating Patients With Locally Advanced Nonmetastatic Bladder Cancer That Can Be Removed By SurgeryNCT00268450
Bladder Cancer
bevacizumab
cisplatin
gemcitabine hyd...
paclitaxel
cysectomy
18 Years - 120 YearsMedical University of South Carolina
Two-Drug Combination Chemotherapy Compared With Four-Drug Combination Chemotherapy in Treating Patients With Advanced Cancer of the UrotheliumNCT00003376
Bladder Cancer
Transitional Ce...
Urethral Cancer
carboplatin
cisplatin
doxorubicin hyd...
methotrexate
paclitaxel
vinblastine
18 Years - 120 YearsEastern Cooperative Oncology Group
Comparison of Immediate and Delayed Adjuvant Chemotherapy in Treating Patients Who Have Undergone a Radical Cystectomy for Stage III or Stage IV Transitional Cell Carcinoma of the Bladder UrotheliumNCT00028756
Stage III Bladd...
Stage IV Bladde...
Transitional Ce...
doxorubicin hyd...
gemcitabine hyd...
vinblastine sul...
methotrexate
cisplatin
filgrastim
- European Organisation for Research and Treatment of Cancer - EORTC
Gemcitabine Hydrochloride and Cisplatin Before Surgery in Treating Patients With Muscle Invasive Bladder CancerNCT01611662
Distal Urethral...
Proximal Urethr...
Squamous Cell C...
Stage II Bladde...
Stage III Bladd...
Urethral Cancer...
gemcitabine hyd...
cisplatin
therapeutic con...
laboratory biom...
18 Years - Fox Chase Cancer Center
Combination Chemotherapy in Treating Patients With Bladder CancerNCT00003701
Bladder Cancer
Urethral Cancer
carboplatin
cisplatin
doxorubicin hyd...
methotrexate
paclitaxel
vinblastine sul...
0 Years - 120 YearsEastern Cooperative Oncology Group
Fluorouracil, Leucovorin, Gemcitabine, and Cisplatin in Treating Patients With Metastatic or Unresectable Adenocarcinoma of the Urothelium or Urachal RemnantNCT00082706
Bladder Cancer
Urethral Cancer
Urachal Cancer
5-Fluorouracil ...
Leucovorin
Cisplatin
Gemcitabine
18 Years - M.D. Anderson Cancer Center
Sorafenib in Treating Patients With Regional or Metastatic Cancer of the UrotheliumNCT00112905
Adenocarcinoma ...
Distal Urethral...
Metastatic Tran...
Proximal Urethr...
Recurrent Bladd...
Recurrent Trans...
Recurrent Ureth...
Regional Transi...
Squamous Cell C...
Stage III Bladd...
Stage IV Bladde...
Transitional Ce...
Urethral Cancer...
sorafenib tosyl...
laboratory biom...
18 Years - National Cancer Institute (NCI)
Cisplatin, Bevacizumab, and Gemcitabine Followed by Surgery, Bevacizumab, and Paclitaxel in Treating Patients With Locally Advanced Nonmetastatic Bladder Cancer That Can Be Removed By SurgeryNCT00268450
Bladder Cancer
bevacizumab
cisplatin
gemcitabine hyd...
paclitaxel
cysectomy
18 Years - 120 YearsMedical University of South Carolina
Ixabepilone in Treating Patients With Advanced Urinary Tract CancerNCT00021099
Distal Urethral...
Metastatic Tran...
Proximal Urethr...
Recurrent Bladd...
Recurrent Trans...
Recurrent Ureth...
Regional Transi...
Stage III Bladd...
Stage IV Bladde...
Transitional Ce...
Urethral Cancer...
ixabepilone
18 Years - National Cancer Institute (NCI)
Standard Surgery or Minimal-Access Surgery in Treating Patients With Bladder CancerNCT01196403
Bladder Cancer
questionnaire a...
quality-of-life...
robot-assisted ...
therapeutic con...
therapeutic lap...
18 Years - National Cancer Institute (NCI)
Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal CancerNCT00003704
Cancer
capecitabine
radiation thera...
18 Years - Alliance for Clinical Trials in Oncology
Sorafenib in Treating Patients With Regional or Metastatic Cancer of the UrotheliumNCT00112905
Adenocarcinoma ...
Distal Urethral...
Metastatic Tran...
Proximal Urethr...
Recurrent Bladd...
Recurrent Trans...
Recurrent Ureth...
Regional Transi...
Squamous Cell C...
Stage III Bladd...
Stage IV Bladde...
Transitional Ce...
Urethral Cancer...
sorafenib tosyl...
laboratory biom...
18 Years - National Cancer Institute (NCI)
Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic CancerNCT00005842
Cancer
trastuzumab
tipifarnib
18 Years - National Cancer Institute (NCI)
Combination Chemotherapy Plus Filgrastim in Treating Patients With Locally Recurrent or Advanced Urothelium CancerNCT00005958
Bladder Cancer
Transitional Ce...
filgrastim
docetaxel
gemcitabine hyd...
18 Years - National Cancer Institute (NCI)
Sunitinib Malate in Treating Patients With Locally Recurrent, Locally Advanced, Unresectable, or Metastatic Urinary Tract CancerNCT01118039
Bladder Cancer
Transitional Ce...
Urethral Cancer
sunitinib malat...
immunohistochem...
laboratory biom...
pharmacological...
quality-of-life...
18 Years - National Cancer Institute (NCI)
Gemcitabine Hydrochloride and Cisplatin Before Surgery in Treating Patients With Muscle Invasive Bladder CancerNCT01611662
Distal Urethral...
Proximal Urethr...
Squamous Cell C...
Stage II Bladde...
Stage III Bladd...
Urethral Cancer...
gemcitabine hyd...
cisplatin
therapeutic con...
laboratory biom...
18 Years - Fox Chase Cancer Center
Celecoxib and Rosiglitazone in Treating Patients Who Are Undergoing Cystoscopic Surveillance for Early-Stage Noninvasive Carcinoma of the Bladder or Radical Cystectomy for Muscle-Invasive Carcinoma of the BladderNCT00084578
Bladder Cancer
celecoxib
rosiglitazone m...
conventional su...
neoadjuvant the...
18 Years - Fox Chase Cancer Center
Combination Chemotherapy Plus Filgrastim in Treating Patients With Locally Recurrent or Advanced Urothelium CancerNCT00005958
Bladder Cancer
Transitional Ce...
filgrastim
docetaxel
gemcitabine hyd...
18 Years - National Cancer Institute (NCI)
Gemcitabine and Irinotecan in Treating Patients With Locally Advanced or Metastatic Bladder CancerNCT00089128
Bladder Cancer
gemcitabine hyd...
irinotecan hydr...
18 Years - 120 YearsMedical University of South Carolina
Gene Therapy in Treating Patients With Advanced Bladder CancerNCT00003167
Recurrent Bladd...
Stage I Bladder...
Stage II Bladde...
Stage III Bladd...
Stage IV Bladde...
Transitional Ce...
Ad5CMV-p53 gene
18 Years - National Cancer Institute (NCI)
Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium and Decreased Kidney FunctionNCT00005644
Bladder Cancer
Transitional Ce...
Urethral Cancer
gemcitabine hyd...
paclitaxel
18 Years - 120 YearsEastern Cooperative Oncology Group
3 Tesla MRI in Patients With Bladder CancerNCT00938145
Bladder Cancer
Specimen Ultra-...
chemotherapy
Cystectomy and ...
18 Years - University of Cincinnati
S1011 Standard or Extended Pelvic Lymphadenectomy in Treating Patients Undergoing Surgery for Invasive Bladder CancerNCT01224665
Bladder Cancer
therapeutic con...
therapeutic sta...
therapeutic ext...
18 Years - 120 YearsSWOG Cancer Research Network
Neoadjuvant Intravesical Vaccine Therapy in Treating Patients With Bladder Carcinoma Who Are Undergoing CystectomyNCT00072137
Bladder Adenoca...
Bladder Squamou...
Bladder Urothel...
Recurrent Bladd...
Stage I Bladder...
Stage II Bladde...
Stage III Bladd...
Stage IV Bladde...
Recombinant Fow...
Recombinant Fow...
Therapeutic Con...
Pharmacological...
Laboratory Biom...
- National Cancer Institute (NCI)
Cisplatin and Gemcitabine Compared With Observation in Treating Patients Who Have Undergone Surgery for Bladder CancerNCT00054626
Bladder Cancer
cisplatin
gemcitabine hyd...
adjuvant therap...
18 Years - 74 YearsNational Cancer Institute (NCI)
Docetaxel and Lapatinib in Metastatic Transitional Cell Carcinoma in BladderNCT01382706
Recurrent Bladd...
Stage III Bladd...
Stage IV Bladde...
Transitional Ce...
docetaxel
lapatinib ditos...
immunohistochem...
fluorescence in...
laboratory biom...
18 Years - University of Southern California
Adjuvant Radiation for High Risk Bladder CancerNCT01954173
Bladder Cancer
Squamous Cell C...
Stage III Bladd...
Stage IV Bladde...
Transitional Ce...
3D conformal ra...
18 Years - Emory University
Fluorouracil, Leucovorin, Gemcitabine, and Cisplatin in Treating Patients With Metastatic or Unresectable Adenocarcinoma of the Urothelium or Urachal RemnantNCT00082706
Bladder Cancer
Urethral Cancer
Urachal Cancer
5-Fluorouracil ...
Leucovorin
Cisplatin
Gemcitabine
18 Years - M.D. Anderson Cancer Center
LMB-9 Immunotoxin in Treating Patients With Advanced Colon, Breast, Non-small Cell Lung, Bladder, Pancreatic, or Ovarian CancerNCT00005858
Bladder Cancer
Breast Cancer
Colorectal Canc...
Lung Cancer
Ovarian Cancer
Pancreatic Canc...
LMB-9 immunotox...
18 Years - University of Maryland, Baltimore
Afatinib in Advanced Refractory Urothelial CancerNCT02122172
Distal Urethral...
Proximal Urethr...
Recurrent Bladd...
Recurrent Ureth...
Stage III Bladd...
Stage III Ureth...
Stage IV Bladde...
Stage IV Urethr...
Ureter Cancer
afatinib dimale...
laboratory biom...
18 Years - University of Chicago
Sirolimus, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Bladder CancerNCT01938573
Recurrent Bladd...
Stage II Bladde...
Stage III Bladd...
Stage IV Bladde...
Cisplatin
Gemcitabine Hyd...
Sirolimus
Cystectomy
18 Years - University of Washington
Lapatinib, Cisplatin, Gemcitabine as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urothelial CancerNCT00623064
Bladder Cancer
Transitional Ce...
cisplatin
gemcitabine hyd...
lapatinib ditos...
pharmacological...
18 Years - European Organisation for Research and Treatment of Cancer - EORTC
Vinorelbine and Paclitaxel Plus Radiation Therapy in Treating Patients With Advanced Cancer Arising in the PelvisNCT00002949
Bladder Cancer
Cervical Cancer
Endometrial Can...
Vaginal Cancer
paclitaxel
vinorelbine tar...
radiation thera...
18 Years - University of Chicago
Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal CancerNCT00003704
Cancer
capecitabine
radiation thera...
18 Years - Alliance for Clinical Trials in Oncology
Surgery With or Without Postoperative Intensity Modulated Radiation Therapy in Treating Patients With Urothelial Bladder CancerNCT02316548
Stage III Bladd...
Stage IV Bladde...
Intensity-Modul...
18 Years - NRG Oncology
Biomarkers in Patients With Kidney Cancer or Cancer of the Urothelium and in Healthy ParticipantsNCT00900276
Bladder Cancer
Kidney Cancer
Transitional Ce...
Urethral Cancer
immunologic tec...
laboratory biom...
mass spectromet...
18 Years - 120 YearsWake Forest University Health Sciences
Docetaxel and Gemcitabine in Treating Patients With Progressive Regional or Metastatic Bladder CancerNCT00004223
Bladder Cancer
Transitional Ce...
Urethral Cancer
docetaxel
gemcitabine hyd...
18 Years - 120 YearsEastern Cooperative Oncology Group
Loop Resectoscope in Treating Patients With Bladder Cancer or Benign Prostatic Hyperplasia Who Are Undergoing Transurethral ResectionNCT00303654
Bladder Cancer
biopsy
therapeutic con...
- National Cancer Institute (NCI)
Combination Chemotherapy and Radiation Therapy With/Without Surgery In Patients With Stage II/III Bladder CancerNCT00055601
Bladder Cancer
cisplatin
fluorouracil
paclitaxel
radiation thera...
Gemcitabine
Radical cystect...
- 120 YearsRadiation Therapy Oncology Group
Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium and Decreased Kidney FunctionNCT00005644
Bladder Cancer
Transitional Ce...
Urethral Cancer
gemcitabine hyd...
paclitaxel
18 Years - 120 YearsEastern Cooperative Oncology Group
Sorafenib in Treating Patients With Advanced or Metastatic Cancer of the Urinary TractNCT00112671
Metastatic Tran...
Recurrent Bladd...
Recurrent Trans...
Regional Transi...
Stage III Bladd...
Stage IV Bladde...
Transitional Ce...
sorafenib tosyl...
laboratory biom...
18 Years - National Cancer Institute (NCI)
Combination Chemotherapy Following Surgery in Treating Patients With Urinary Tract CancerNCT00028860
Bladder Cancer
Transitional Ce...
filgrastim
carboplatin
gemcitabine hyd...
ifosfamide
paclitaxel
adjuvant therap...
- National Cancer Institute (NCI)
Transurethral Resection and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder CancerNCT00003640
Bladder Cancer
filgrastim
cisplatin
doxorubicin hyd...
methotrexate
vinblastine sul...
surgical proced...
radiation thera...
- European Organisation for Research and Treatment of Cancer - EORTC
Pemetrexed Disodium and Gemcitabine in Treating Patients With Advanced Cancer of the UrotheliumNCT00053209
Bladder Cancer
Transitional Ce...
Urethral Cancer
gemcitabine hyd...
pemetrexed diso...
18 Years - 120 YearsEastern Cooperative Oncology Group
Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or LymphomaNCT03229278
Lymphoma
Metastatic Mali...
Metastatic Mela...
Metastatic Rena...
Recurrent Bladd...
Recurrent Class...
Recurrent Head ...
Recurrent Lymph...
Recurrent Malig...
Recurrent Renal...
Stage III Bladd...
Stage III Lymph...
Stage III Non-S...
Stage III Renal...
Stage III Skin ...
Stage IIIA Non-...
Stage IIIA Skin...
Stage IIIB Non-...
Stage IIIB Skin...
Stage IIIC Skin...
Stage IV Bladde...
Stage IV Lympho...
Stage IV Non-Sm...
Stage IV Renal ...
Stage IV Skin M...
Stage IVA Bladd...
Stage IVB Bladd...
Unresectable He...
Unresectable So...
Enzyme Inhibito...
Laboratory Biom...
Nivolumab
Pembrolizumab
18 Years - Rutgers, The State University of New Jersey
Neoadjuvant Intravesical Vaccine Therapy in Treating Patients With Bladder Carcinoma Who Are Undergoing CystectomyNCT00072137
Bladder Adenoca...
Bladder Squamou...
Bladder Urothel...
Recurrent Bladd...
Stage I Bladder...
Stage II Bladde...
Stage III Bladd...
Stage IV Bladde...
Recombinant Fow...
Recombinant Fow...
Therapeutic Con...
Pharmacological...
Laboratory Biom...
- National Cancer Institute (NCI)
Cisplatin, Bevacizumab, and Gemcitabine Followed by Surgery, Bevacizumab, and Paclitaxel in Treating Patients With Locally Advanced Nonmetastatic Bladder Cancer That Can Be Removed By SurgeryNCT00268450
Bladder Cancer
bevacizumab
cisplatin
gemcitabine hyd...
paclitaxel
cysectomy
18 Years - 120 YearsMedical University of South Carolina
Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Bladder CancerNCT00003105
Bladder Cancer
Transitional Ce...
filgrastim
cisplatin
doxorubicin hyd...
gemcitabine hyd...
ifosfamide
paclitaxel
18 Years - Memorial Sloan Kettering Cancer Center
Green Tea Extract in Treating Patients With Nonmetastatic Bladder CancerNCT00666562
Stage I Bladder...
Stage II Bladde...
Stage III Bladd...
Defined Green T...
Laboratory Biom...
Pharmacological...
Placebo
Therapeutic Con...
18 Years - National Cancer Institute (NCI)
Sirolimus, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Bladder CancerNCT01938573
Recurrent Bladd...
Stage II Bladde...
Stage III Bladd...
Stage IV Bladde...
Cisplatin
Gemcitabine Hyd...
Sirolimus
Cystectomy
18 Years - University of Washington
Afatinib in Advanced Refractory Urothelial CancerNCT02122172
Distal Urethral...
Proximal Urethr...
Recurrent Bladd...
Recurrent Ureth...
Stage III Bladd...
Stage III Ureth...
Stage IV Bladde...
Stage IV Urethr...
Ureter Cancer
afatinib dimale...
laboratory biom...
18 Years - University of Chicago
Gene Therapy in Treating Patients With CancerNCT00004178
Cancer
therapeutic aut...
18 Years - Roger Williams Medical Center
Sunitinib Malate in Treating Patients With Locally Recurrent, Locally Advanced, Unresectable, or Metastatic Urinary Tract CancerNCT01118039
Bladder Cancer
Transitional Ce...
Urethral Cancer
sunitinib malat...
immunohistochem...
laboratory biom...
pharmacological...
quality-of-life...
18 Years - National Cancer Institute (NCI)
Radiation Therapy or Surgery in Treating Patients Receiving Chemotherapy for Bladder CancerNCT00867347
Bladder Cancer
therapeutic con...
radiation thera...
18 Years - 120 YearsInstitute of Cancer Research, United Kingdom
Vinorelbine and Paclitaxel Plus Radiation Therapy in Treating Patients With Advanced Cancer Arising in the PelvisNCT00002949
Bladder Cancer
Cervical Cancer
Endometrial Can...
Vaginal Cancer
paclitaxel
vinorelbine tar...
radiation thera...
18 Years - University of Chicago
Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic CancerNCT00004065
Bladder Cancer
Breast Cancer
Colorectal Canc...
Gastric Cancer
Head and Neck C...
Kidney Cancer
Leukemia
Lung Cancer
Melanoma (Skin)
Ovarian Cancer
Prostate Cancer
Unspecified Adu...
tanespimycin
18 Years - Memorial Sloan Kettering Cancer Center
S0219, Combination Chemotherapy Followed By Observation or Surgery in Patients With Stage II or Stage III Cancer of the UrotheliumNCT00045630
Bladder Cancer
Transitional Ce...
Urethral Cancer
carboplatin
gemcitabine
paclitaxel
surgery
18 Years - SWOG Cancer Research Network
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: